[Federal Register Volume 75, Number 17 (Wednesday, January 27, 2010)]
[Notices]
[Pages 4396-4397]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-1653]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-10-09AM]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
Alternatively, to obtain a copy of the data collection plans and
instrument, call 404-639-5960 and send comments to Maryam I. Daneshvar,
CDC Reports Clearance Officer, 1600 Clifton Road NE., MS-D74, Atlanta,
Georgia 30333; comments may also be sent by e-mail to [email protected].
Comments are invited on (a) whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have a practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarify of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of information technology. Written comments
should be received within 60 days of this notice.
Proposed Project
Prevalence Survey of Healthcare Associated Infections (HAIs) and
Antimicrobial Use in U.S. Acute Care Hospitals--New--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID) (proposed),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval to conduct two surveys to obtain
national estimates of Healthcare Associated Infections (HAIs)
prevalence and antimicrobial use in the United States. Preventing HAIs
is a CDC priority, and an essential step in reducing the occurrence of
HAIs is to accurately estimate the burden of these infections in U.S.
hospitals and to describe the types of HAIs and their causative
organisms, including antimicrobial-resistant pathogens.
The scope and magnitude of HAIs in the U.S. were last directly
estimated in the 1970s and 1980s by CDC's Study on the Efficacy of
Nosocomial Infection Control (SENIC), in which comprehensive data were
collected from a sample of 338 hospitals; 5% of hospitalized patients
acquired an infection not present at the time of admission. CDC's
current HAI surveillance system, the National Healthcare Safety Network
(NHSN) (OMB Control No. 0920-0666, expiration date 9/30/2012), focuses
instead on device-associated and procedure-associated infections in a
variety of patient locations, and does not receive data on all types of
HAIs to make hospital-wide burden estimates. The purpose of this
information collection request is to assess the magnitude and types of
HAIs and antimicrobial use occurring in all patient populations within
acute care hospitals in order to inform decisions made by local and
national policy makers and hospital infection control personnel
regarding appropriate targets and strategies for preventing HAIs and
the emergence of antimicrobial- resistant pathogens and encouraging
appropriate antimicrobial use. Such assessments can be obtained in
periodic national prevalence studies, such as
[[Page 4397]]
those that have been conducted in several European countries.
CDC proposes to conduct two surveys to collect this data. The first
survey will be a limited roll-out survey and will be conducted in 30
facilities across 10 States in collaboration with State public health
authorities and CDC's Emerging Infections Program (EIP). The survey
will be conducted on a single day in participating facilities.
Infection Control Practitioners in participating facilities, such as
infection control personnel, will collect limited demographic and
clinical information on a sample of eligible inpatients and, on the
same day, EIP site personnel will collect information on HAIs and
antimicrobial use for surveyed patients who are on antimicrobial
therapy at the time of the survey. The second survey will involve 500
facilities across the same 10 States and use the same methodology. As
with the first survey, CDC will collaborate with State public health
authorities and EIP sites.
CDC will use the data provided to estimate the prevalence of HAIs
and antimicrobial use across this sample of U.S. hospitals as well as
to estimate the distribution of infection types, causative organisms,
and nature of and rationale for antimicrobial use.
This proposed project supports CDC's Strategic Goal of ``Healthy
Healthcare Settings,'' specifically the objectives to ``Promote
compliance with evidence-based guidelines for preventing, identifying,
and managing disease in healthcare settings'' and ``Prevent adverse
events in patients and healthcare workers in healthcare settings.''
There are no costs to respondents, other than their time to complete
the survey.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Infection Control Practitioners--Survey 1............................................
EIP personnel--Survey 1................ 10 99 15/60 248
Infection Control Practitioners--Survey 2............................................
EIP personnel--Survey 2................ 10 1650 15/60 4,125
---------------------------------------------------------------
Total....................................... .............. .............. .............. 8,039
----------------------------------------------------------------------------------------------------------------
Dated: January 22, 2010.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-1653 Filed 1-26-10; 8:45 am]
BILLING CODE 4163-18-P